Overview

Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety and efficacy of 5.0% and 7.5% AN2690 Solution in the treatment of distal, subungual onychomycosis of the great target toenail.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Pharmaceutical Solutions
Tavaborole